Complications and treatment of patients with β-thalassemia in France: results of the National Registry.
about
Current and future alternative therapies for beta-thalassemia majorKLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemiaPreclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review.Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the diseaseManagement of transfusional iron overload - differential properties and efficacy of iron chelating agents.Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.β-Thalassemia and ocular implications: a systematic review.Challenges of alloimmunization in patients with haemoglobinopathies.National registry of hemoglobinopathies in Spain (REPHem).The Italian multiregional thalassemia registry: Centers characteristics, services, and patients' population.The Prevalence of Hemoglobinopathies in Young Adolescents in the Province of Muğla in Turkey: Results of a Screening Program.Rapid Targeted Next-Generation Sequencing Platform for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies.Anemia in children: prevalence, causes, diagnostic work-up, and long-term consequences.Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.Treatment and complications of thalassemia major in Guangxi, Southern China.Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian WEBTHAL project.Low-dose Synachten test with measurement of salivary cortisol in adult patients with β-thalassemia major.The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders.Growth and Endocrine Function in Tunisian Thalassemia Major Patients.Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience.
P2860
Q26750906-43AC6469-A9F1-4B58-982F-0D9AFFCCB0B6Q33987100-00B45282-3B41-4E6D-85C8-473169EB18DAQ34449867-9E72878A-31EE-4643-9EC5-BCB1FFE1910AQ34569009-499143DC-2827-4130-B4C7-15B23E33666EQ35528718-B916A849-E21D-49EF-A5C0-8B1A0CE28256Q35683841-746BEE78-C82A-4B9F-A31A-C7065CEAAD33Q35881019-CB14B044-FF29-4853-B5AD-ED01317448CDQ36070750-56953E47-6193-470C-A0D5-74EE490805BDQ38049189-D2F436A8-C666-4F13-9A0D-F4D49EACE200Q38800491-FE240B22-CFDA-48A2-AEC4-971BA4D5A508Q40008183-DB4B81D4-6A80-4D26-B53C-AB9C2E47B614Q41633088-FE4FAD2D-B9B8-476A-AFB2-A09F61651024Q41688378-834161E4-FB38-4109-A8B1-9BA7BAEB47F0Q41986646-574EBA5C-1638-4CE1-BA90-93D1C19DDC74Q43934420-355E0EC0-6AC2-4F34-8E3F-D3D595D6F78FQ44639942-E5663785-C410-4E46-B0A0-A3642E7292E6Q46152924-9DF558F0-F8CA-47A1-B80A-DD94D3EFB797Q47552115-02A8A2FA-A3E0-4478-BF92-D8FBD0C49CA6Q51877530-98C84CDE-7AAE-4EED-8C89-20625B4D8389Q52639244-22EE56A1-81DD-4C9A-BA4B-C4BD262BE833Q53112355-4C20FE7E-3A14-4BAF-989A-E1A03A459ACFQ55243761-E6BE890E-D632-40F5-91F6-F7FF6C58AFB2Q55638215-9AE5ED57-AC22-4CD7-A559-5D70311E52BB
P2860
Complications and treatment of patients with β-thalassemia in France: results of the National Registry.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Complications and treatment of ...... ults of the National Registry.
@ast
Complications and treatment of ...... ults of the National Registry.
@en
type
label
Complications and treatment of ...... ults of the National Registry.
@ast
Complications and treatment of ...... ults of the National Registry.
@en
prefLabel
Complications and treatment of ...... ults of the National Registry.
@ast
Complications and treatment of ...... ults of the National Registry.
@en
P2093
P2860
P1433
P1476
Complications and treatment of ...... ults of the National Registry.
@en
P2093
Anderson Loundou
Catherine Badens
Christian Rose
Claire Berger
Corinne Pondarré
Dominique Steschenko
Dora Bachir
Françoise Bernaudin
Frédéric Galactéros
Isabelle Hagege
P2860
P304
P356
10.3324/HAEMATOL.2009.018051
P577
2009-12-08T00:00:00Z